Published On: 11th April, 2025 In a decisive move aimed at promoting manufacturing and sale of medical devices for domestic and export market, the Central Drugs Standard Control Organization (CDSCO) has announced a significant upgrade in its online licensing system.…
Recent Post
- India brings Pregabalin under Schedule H1
- CDSCO Issues Stern Warning Against Injectable Cosmetics and Misleading Beauty Claims
- CDSCO Orders Nationwide Crackdown on Unauthorised GLP-1 Weight Loss Drugs
- Drug Applications with Unanswered Queries to Be Rejected Within 30 Days by CDSCO
- ⚖️ “No Approval, No Market”: Delhi High Court Sends a Strong Message on Unapproved Drugs & FDCs
